LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,940
تعداد دریافت فایل اصل مقاله11,291,572
Mohamadi-Zarch, Seyed-Mahdi, Baluchnejadmojarad, Tourandokht, Nourabadi, Davood, Ramazi, Samira, Nazari-Serenjeh, Morteza, Roghani, Mehrdad. (1400). Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice. سامانه مدیریت نشریات علمی, 46(5), 373-382. doi: 10.30476/ijms.2020.84909.1474
Seyed-Mahdi Mohamadi-Zarch; Tourandokht Baluchnejadmojarad; Davood Nourabadi; Samira Ramazi; Morteza Nazari-Serenjeh; Mehrdad Roghani. "Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice". سامانه مدیریت نشریات علمی, 46, 5, 1400, 373-382. doi: 10.30476/ijms.2020.84909.1474
Mohamadi-Zarch, Seyed-Mahdi, Baluchnejadmojarad, Tourandokht, Nourabadi, Davood, Ramazi, Samira, Nazari-Serenjeh, Morteza, Roghani, Mehrdad. (1400). 'Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice', سامانه مدیریت نشریات علمی, 46(5), pp. 373-382. doi: 10.30476/ijms.2020.84909.1474
Mohamadi-Zarch, Seyed-Mahdi, Baluchnejadmojarad, Tourandokht, Nourabadi, Davood, Ramazi, Samira, Nazari-Serenjeh, Morteza, Roghani, Mehrdad. Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice. سامانه مدیریت نشریات علمی, 1400; 46(5): 373-382. doi: 10.30476/ijms.2020.84909.1474

Esculetin Alleviates Acute Liver Failure following Lipopolysaccharide/D-Galactosamine in Male C57BL/6 Mice

Iranian Journal of Medical Sciences
مقاله 7، دوره 46، شماره 5، آذر 2021، صفحه 373-382    اصل مقاله (1.5 M)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2020.84909.1474
نویسندگان
Seyed-Mahdi Mohamadi-Zarch1؛ Tourandokht Baluchnejadmojarad* 1؛ Davood Nourabadi1؛ Samira Ramazi1؛ Morteza Nazari-Serenjeh1؛ Mehrdad Roghani2
1Department of Physiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2Neurophysiology Research Center, Shahed University, Tehran, Iran
چکیده
Background: Acute liver failure (ALF) is a fatal clinical situation that rapidly leads to the loss of normal liver function. Esculetin is a natural herbal compound used for the management of various diseases such as cardiovascular and renal disorders. In this study, we evaluated the protective effects of esculetin in a mouse model of ALF.
Methods: This article is a report on an experimental study that was conducted at Iran University of Medical Sciences in 2019. Forty-eight male C57BL/6 mice were randomly divided into control, LPS/D-Gal, and LPS/D-Gal+Esculetin (40 mg/kg) groups (n=16 per group). ALF was induced with an intraperitoneal injection of lipopolysaccharide (LPS)/D-galactosamine (D-Gal).The LPS/D-Gal group received a mixture of LPS (50 μg/kg) and D-Gal (400 mg/kg). The LPS/D-Gal+Esculetin group received esculetin by gavage 24 hours and one hour before receiving LPS/D-Gal. Six hours after LPS/D-Gal injection, the mice were sacrificed. Liver injury markers, including alanine aminotransferase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP), were measured in the serum. Oxidative stress indices and inflammatory markers such as interleukin-1 beta (IL-1β), IL-6, and tumor necrosis factor-alpha (TNF-α) were measured in hepatic tissue. The histopathology of liver tissue was also assessed. The data were analyzed using one-way ANOVA, followed by the post hoc Tukey test.
Results: Esculetin lowered oxidative stress and myeloperoxidase activity (p <0.001); reduced the serum levels of ALT (P=0.037), AST (P=0.032), and ALP (P=0.004); and decreased the hepatic levels of IL-1β (P=0.002), IL-6 (P=0.004), toll-like receptor 4 (p <0.001), TNF-α (P=0.003), and nuclear factor-kappa B (p <0.001) as compared with LPS/D-Gal. Additionally, esculetin ameliorated hepatic tissue injury following LPS/D-Gal challenge.
Conclusion: Esculetin can reduce liver injury through the mitigation of oxidative burden, inflammation, and neutrophil infiltration and also exerts hepatoprotective effects against ALF.
کلیدواژه‌ها
Liver failure, Acute؛ Lipopolysaccharides؛ Inflammation؛ Oxidative stress
سایر فایل های مرتبط با مقاله
مراجع
  1. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. 2000;6:163-9. doi: 10.1002/lt.500060218. PubMed PMID: 10719014.
  2. Katarey D, Verma S. Drug-induced liver injury. Clin Med (Lond). 2016;16:s104-s9. doi: 10.7861/clinmedicine.16-6-s104. PubMed PMID: 27956449; PubMed Central PMCID: PMCPMC6329561.
  3. Soares JB, Pimentel-Nunes P, Roncon-Albuquerque R, Leite-Moreira A. The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. Hepatol Int. 2010;4:659-72. doi: 10.1007/s12072-010-9219-x. PubMed PMID: 21286336; PubMed Central PMCID: PMCPMC2994611.
  4. Farghali H, Kgalalelo Kemelo M, Wojnarova L, Kutinova Canova N. In vitro and in vivo experimental hepatotoxic models in liver research: applications to the assessment of potential hepatoprotective drugs. Physiol Res. 2016;65:S417-S25. doi: 10.33549/physiolres.933506. PubMed PMID: 28006924.
  5. Yang P, Zhou W, Li C, Zhang M, Jiang Y, Jiang R, et al. Kupffer-cell-expressed transmembrane TNF-alpha is a major contributor to lipopolysaccharide and D-galactosamine-induced liver injury. Cell Tissue Res. 2016;363:371-83. doi: 10.1007/s00441-015-2252-2. PubMed PMID: 26267221.
  6. Liedtke C, Trautwein C. The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer. Eur J Cell Biol. 2012;91:582-9. doi: 10.1016/j.ejcb.2011.10.001. PubMed PMID: 22153863.
  7. Hoult JR, Paya M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol. 1996;27:713-22. doi: 10.1016/0306-3623(95)02112-4. PubMed PMID: 8853310.
  8. Liang C, Ju W, Pei S, Tang Y, Xiao Y. Pharmacological Activities and Synthesis of Esculetin and Its Derivatives: A Mini-Review. Molecules. 2017;22. doi: 10.3390/molecules22030387. PubMed PMID: 28257115; PubMed Central PMCID: PMCPMC6155195.
  9. Lin WL, Wang CJ, Tsai YY, Liu CL, Hwang JM, Tseng TH. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver. Arch Toxicol. 2000;74:467-72. doi: 10.1007/s002040000148. PubMed PMID: 11097384.
  10. Han MH, Park C, Lee DS, Hong SH, Choi IW, Kim GY, et al. Cytoprotective effects of esculetin against oxidative stress are associated with the upregulation of Nrf2-mediated NQO1 expression via the activation of the ERK pathway. Int J Mol Med. 2017;39:380-6. doi: 10.3892/ijmm.2016.2834. PubMed PMID: 28000844.
  11. Chen T, Guo Q, Wang H, Zhang H, Wang C, Zhang P, et al. Effects of esculetin on lipopolysaccharide (LPS)-induced acute lung injury via regulation of RhoA/Rho Kinase/NF-small ka, CyrillicB pathways in vivo and in vitro. Free Radic Res. 2015;49:1459-68. doi: 10.3109/10715762.2015.1087643. PubMed PMID: 26514440.
  12. Gong X, Yang Y, Huang L, Zhang Q, Wan RZ, Zhang P, et al. Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS/d-GalN-induced acute liver failure in mice. Int Immunopharmacol. 2017;46:124-32. doi: 10.1016/j.intimp.2017.03.003. PubMed PMID: 28282576.
  13. Tien YC, Liao JC, Chiu CS, Huang TH, Huang CY, Chang WT, et al. Esculetin ameliorates carbon tetrachloride-mediated hepatic apoptosis in rats. Int J Mol Sci. 2011;12:4053-67. doi: 10.3390/ijms12064053. PubMed PMID: 21747724; PubMed Central PMCID: PMCPMC3131608.
  14. Care Gft, Animals UoL. National Research Council (US) Committee for the update of the guide for the care and use of laboratory animals. Washington: National Academies Press; 2011.
  15. Hongyan L. Esculetin Attenuates Th2 and Th17 Responses in an Ovalbumin-Induced Asthmatic Mouse Model. Inflammation. 2016;39:735-43. doi: 10.1007/s10753-015-0300-4. PubMed PMID: 26797918.
  16. Jia YN, Lu HP, Peng YL, Zhang BS, Gong XB, Su J, et al. Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice. Int Immunopharmacol. 2018;56:105-12. doi: 10.1016/j.intimp.2018.01.014. PubMed PMID: 29414639.
  17. Li L, Yin H, Zhao Y, Zhang X, Duan C, Liu J, et al. Protective role of puerarin on LPS/D-Gal induced acute liver injury via restoring autophagy. Am J Transl Res. 2018;10:957-65. PubMed PMID: 29636885; PubMed Central PMCID: PMCPMC5883136.
  18. Sedaghat R, Roghani M, Khalili M. Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model. Iran J Pharm Res. 2014;13:227-34. PubMed PMID: 24734075; PubMed Central PMCID: PMCPMC3985249.
  19. Zeb A, Ullah F. A Simple Spectrophotometric Method for the Determination of Thiobarbituric Acid Reactive Substances in Fried Fast Foods. J Anal Methods Chem. 2016;2016:9412767. doi: 10.1155/2016/9412767. PubMed PMID: 27123360; PubMed Central PMCID: PMCPMC4830699.
  20. Arya A, Sethy NK, Singh SK, Das M, Bhargava K. Cerium oxide nanoparticles protect rodent lungs from hypobaric hypoxia-induced oxidative stress and inflammation. Int J Nanomedicine. 2013;8:4507-20. doi: 10.2147/IJN.S53032. PubMed PMID: 24294000; PubMed Central PMCID: PMCPMC3839803.
  21. Majithiya JB, Balaraman R. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. Life Sci. 2006;78:2615-24. doi: 10.1016/j.lfs.2005.10.020. PubMed PMID: 16318863.
  22. Raoufi S, Baluchnejadmojarad T, Roghani M, Ghazanfari T, Khojasteh F, Mansouri M. Antidiabetic potential of salvianolic acid B in multiple low-dose streptozotocin-induced diabetes. Pharm Biol. 2015;53:1803-9. doi: 10.3109/13880209.2015.1008148. PubMed PMID: 25885938.
  23. Kiasalari Z, Roghani M, Khalili M, Rahmati B, Baluchnejadmojarad T. Antiepileptogenic effect of curcumin on kainate-induced model of temporal lobe epilepsy. Pharm Biol. 2013;51:1572-8. doi: 10.3109/13880209.2013.803128. PubMed PMID: 24004105.
  24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54. doi: 10.1006/abio.1976.9999. PubMed PMID: 942051.
  25. Khosravi Z, Sedaghat R, Baluchnejadmojarad T, Roghani M. Diosgenin ameliorates testicular damage in streptozotocin-diabetic rats through attenuation of apoptosis, oxidative stress, and inflammation. Int Immunopharmacol. 2019;70:37-46. doi: 10.1016/j.intimp.2019.01.047. PubMed PMID: 30785089.
  26. Gao YZ, Zhao LF, Ma J, Xue WH, Zhao H. Protective mechanisms of wogonoside against Lipopolysaccharide/D-galactosamine-induced acute liver injury in mice. Eur J Pharmacol. 2016;780:8-15. doi: 10.1016/j.ejphar.2016.02.040. PubMed PMID: 26921756.
  27. Farhana A, Khan YS. Biochemistry, Lipopolysaccharide. Treasure Island: StatPearls Publishing; 2020.
  28. Yang H, Young DW, Gusovsky F, Chow JC. Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem. 2000;275:20861-6. doi: 10.1074/jbc.M002896200. PubMed PMID: 10877845.
  29. Streetz K, Leifeld L, Grundmann D, Ramakers J, Eckert K, Spengler U, et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology. 2000;119:446-60. doi: 10.1053/gast.2000.9364. PubMed PMID: 10930380.
  30. Li Z, Feng H, Wang Y, Shen B, Tian Y, Wu L, et al. Rosmarinic acid protects mice from lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting MAPKs/NF-kappaB and activating Nrf2/HO-1 signaling pathways. Int Immunopharmacol. 2019;67:465-72. doi: 10.1016/j.intimp.2018.12.052. PubMed PMID: 30597292.
  31. Yang F, Li X, Wang LK, Wang LW, Han XQ, Zhang H, et al. Inhibitions of NF-kappaB and TNF-alpha result in differential effects in rats with acute on chronic liver failure induced by d-Gal and LPS. Inflammation. 2014;37:848-57. doi: 10.1007/s10753-013-9805-x. PubMed PMID: 24385241.
  32. Iannitti RG, Napolioni V, Oikonomou V, De Luca A, Galosi C, Pariano M, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. Nat Commun. 2016;7:10791. doi: 10.1038/ncomms10791. PubMed PMID: 26972847; PubMed Central PMCID: PMCPMC4793079.
  33. Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest. 2012;122:3476-89. doi: 10.1172/JCI60777. PubMed PMID: 22945633; PubMed Central PMCID: PMCPMC3461900.
  34. Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 2010;139:323-34. doi: 10.1053/j.gastro.2010.03.052. PubMed PMID: 20347818; PubMed Central PMCID: PMCPMC4631262.
  35. Petrasek J, Dolganiuc A, Csak T, Kurt-Jones EA, Szabo G. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice. Gastroenterology. 2011;140:697-708 e4. doi: 10.1053/j.gastro.2010.08.020. PubMed PMID: 20727895; PubMed Central PMCID: PMCPMC3031737.
  36. Zhang ZH, Zhu W, Ren HZ, Zhao X, Wang S, Ma HC, et al. Mesenchymal stem cells increase expression of heme oxygenase-1 leading to anti-inflammatory activity in treatment of acute liver failure. Stem Cell Res Ther. 2017;8:70. doi: 10.1186/s13287-017-0524-3. PubMed PMID: 28320485; PubMed Central PMCID: PMCPMC5359839.
  37. Gong X, Cao P, Liu L, Lin Y, Yang Q, Zhou L, et al. Tamoxifen Prevents D-galactosamine/Lipopolysaccharide-Induced Murine Acute Hepatic Failure through Inhibition of Oxidative Stress and Mmd-2 Upregulation. Immunol Invest. 2018;47:547-57. doi: 10.1080/08820139.2018.1464024. PubMed PMID: 29775111.
  38. Carvalho NR, Tassi CC, Dobraschinski F, Amaral GP, Zemolin AP, Golombieski RM, et al. Reversal of bioenergetics dysfunction by diphenyl diselenide is critical to protection against the acetaminophen-induced acute liver failure. Life Sci. 2017;180:42-50. doi: 10.1016/j.lfs.2017.05.012. PubMed PMID: 28501483.
  39. Klaassen CD, Reisman SA. Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver. Toxicol Appl Pharmacol. 2010;244:57-65. doi: 10.1016/j.taap.2010.01.013. PubMed PMID: 20122946; PubMed Central PMCID: PMCPMC2860427.
آمار
تعداد مشاهده مقاله: 4,653
تعداد دریافت فایل اصل مقاله: 2,816


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب